Inactive Instrument
ONCODESIGN Share Price
Stocks
ALONC
FR0011766229
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Aidan Synnott
CEO | Chief Executive Officer | 48 | 11/04/2025 |
Fabrice Viviani
CEO | Chief Executive Officer | - | 05/11/2022 |
Arnaud Lafforgue
DFI | Director of Finance/CFO | - | 24/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Karine Lignel
BRD | Director/Board Member | 58 | 14/05/2008 |
Kamel Besseghir
BRD | Director/Board Member | 78 | 03/02/2014 |
Aline Aubertin
BRD | Director/Board Member | - | 24/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/12/22 | Buy | Chief Executive Officer | 18,480 | 0.2673% | ||
| 24/10/22 | Sell | Chief Technology Officer | 17,640 | 0.2576% | ||
| 24/10/22 | Sell | Chief Financial Officer | 21,230 | 0.3100% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -0.14% | - | - | 11Cr | ||
| +2.64% | +6.45% | +11.87% | +38.40% | 4.8TCr | ||
| +0.22% | +0.40% | +50.91% | +37.06% | 4.45TCr | ||
| -1.58% | +4.66% | +359.34% | +614.38% | 4.39TCr | ||
| +1.70% | +0.36% | +12.56% | +99.27% | 4.1TCr | ||
| +0.51% | -1.71% | +5.18% | +46.87% | 2.99TCr | ||
| -0.48% | -1.32% | +23.98% | +150.01% | 1.73TCr | ||
| +0.08% | +9.03% | +8.41% | - | 1.53TCr | ||
| +1.76% | +0.85% | +29.13% | +48.42% | 1.53TCr | ||
| +1.97% | -3.17% | - | - | 1.48TCr | ||
| Average | +0.68% | +1.63% | +62.67% | +147.77% | 3TCr | |
| Weighted average by Cap. | +0.74% | +1.89% | +79.47% | +163.79% |
Employees
236
















